Beijing Hotgen Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	120.55	270.15	276.11	523.49	1,161	382.62
Short-Term Investments	303.26	601.14	50	50.95	-	-
Trading Asset Securities	669.32	201.51	280.02	888.68	927.45	-
Cash & Short-Term Investments	1,093	1,073	606.13	1,463	2,089	382.62
Cash Growth	8.21%	76.99%	-58.57%	-29.94%	445.84%	-9.51%
Accounts Receivable	131.42	92.49	28.59	102.04	38.21	29.13
Other Receivables	3.2	24.13	28.93	17.01	47.36	2.54
Receivables	134.62	116.62	57.52	119.06	85.57	31.68
Inventory	77.91	83.45	137.21	154.25	258.62	126.31
Prepaid Expenses	-	-	0.15	2.6	-	-
Other Current Assets	33.15	19.55	38.9	59.24	84.98	47.16
Total Current Assets	1,339	1,292	839.91	1,798	2,518	587.77
Property, Plant & Equipment	1,017	1,074	1,193	867.94	562.12	237.38
Long-Term Investments	726.98	826.04	1,418	1,038	441.6	-
Other Intangible Assets	49.48	52.12	55.07	56.55	57.33	58.45
Long-Term Deferred Tax Assets	28.69	26.64	34.4	38.8	15.95	3.15
Long-Term Deferred Charges	20.6	25.55	24.3	23.2	22.32	10.56
Other Long-Term Assets	25.81	29.3	6.76	76.21	27.85	5.21
Total Assets	3,208	3,326	3,572	3,899	3,645	902.52
Accounts Payable	140.76	46.12	44.72	151.52	141.27	66.24
Accrued Expenses	16.28	30.23	25.55	177.68	167.53	36.63
Short-Term Debt	50	-	-	-	-	-
Current Portion of Leases	0.08	0.12	7.49	27.95	13	-
Current Income Taxes Payable	9.89	1.06	1.15	1.13	120.24	16.7
Current Unearned Revenue	14.51	16.7	28.08	56.98	267.05	12.71
Other Current Liabilities	32.8	141.66	81.05	96.06	25.08	11.84
Total Current Liabilities	264.32	235.89	188.04	511.31	734.16	144.11
Long-Term Leases	0.04	0.12	7.76	14.18	22.98	-
Long-Term Unearned Revenue	13.89	15.75	9.77	10.77	9.47	9.61
Long-Term Deferred Tax Liabilities	-	-	-	9.32	4.41	2
Total Liabilities	278.25	251.77	205.57	545.59	771.01	155.72
Common Stock	92.71	92.47	92.27	92.05	62.2	62.2
Additional Paid-In Capital	336.95	321.41	444.04	435.31	458.31	449.85
Retained Earnings	2,677	2,786	2,994	2,958	2,323	230.85
Treasury Stock	-188.58	-133.89	-166.48	-150.04	-	-
Comprehensive Income & Other	15.06	9.96	4.32	-0.03	-0.3	-0.16
Total Common Equity	2,933	3,076	3,368	3,335	2,844	742.73
Minority Interest	-3.24	-1.43	-2.12	18.46	30.31	4.06
Shareholders' Equity	2,930	3,074	3,366	3,354	2,874	746.79
Total Liabilities & Equity	3,208	3,326	3,572	3,899	3,645	902.52
Total Debt	50.11	0.24	15.26	42.13	35.98	-
Net Cash (Debt)	1,043	1,073	590.87	1,421	2,053	382.62
Net Cash Growth	4.12%	81.52%	-58.42%	-30.77%	436.43%	-4.13%
Net Cash Per Share	11.65	11.61	6.69	15.46	22.30	4.15
Filing Date Shares Outstanding	88.83	89.58	89.41	89.53	92.05	92.05
Total Common Shares Outstanding	88.83	89.58	89.41	89.53	92.05	92.05
Working Capital	1,074	1,057	651.88	1,287	1,784	443.66
Book Value Per Share	33.01	34.33	37.67	37.25	30.89	8.07
Tangible Book Value	2,883	3,023	3,313	3,279	2,786	684.28
Tangible Book Value Per Share	32.46	33.75	37.06	36.62	30.27	7.43
Buildings	-	703.6	704.79	174.55	162.16	55.38
Machinery	-	567.73	575.66	399.88	317.94	196.3
Construction In Progress	-	5.62	48.18	374.44	121.71	55.45

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.